Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.25 USD | -0.77% | +0.28% | -12.59% |
Mar. 27 | UBS Cuts BioNTech Price Target to $101 From $110, Maintains Neutral Rating | MT |
Mar. 26 | News Highlights : Top Company News of the Day - Tuesday at 7 AM ET | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.59% | 21.93B | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B | |
-6.78% | 10.2B |
- Stock
- Equities
- Stock BioNTech SE - Nasdaq
- News BioNTech SE
- BioNTech : Plans Development of First mRNA-Based Malaria Vaccine